Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Distributing estrogen patient package inserts to institutional patients

B G Kay, D N Adelman

    American Journal of Hospital Pharmacy
    |September 1, 1978
    PubMed
    Summary

    A new procedure ensures patient package inserts (PPIs) for estrogens are distributed to both outpatients and inpatients. Pharmacists reinforce PPI information, and physician compliance is mandatory before estrogen administration.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Overcoming unit dose drug distribution system logistical problems on a 32-acre campus.

    Hospital pharmacy·1992
    Same author

    Documenting concurrent clinical pharmacy interventions.

    Hospital pharmacy·1990
    Same author

    Microbiology of indwelling central intravascular catheters.

    Journal of clinical microbiology·1988
    Same author

    Try this simple T.P.N. order form.

    Nursing·1987
    Same author

    Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteers.

    Cancer treatment reports·1987
    Same author

    Designing a modern hospital pharmacy.

    American journal of hospital pharmacy·1986

    Area of Science:

    • Pharmacology
    • Patient Education
    • Drug Safety

    Background:

    • Patient package inserts (PPIs) are crucial for informing patients about medication risks and benefits.
    • Ensuring proper distribution and understanding of PPIs for hormone therapy, such as estrogens, is vital for patient safety.
    • Existing methods for PPI distribution may be inconsistent, particularly for ambulatory and home healthcare settings.

    Purpose of the Study:

    • To develop and implement a standardized procedure for distributing patient package inserts (PPIs) for estrogen medications.
    • To enhance patient comprehension and physician adherence regarding estrogen therapy information.
    • To ensure estrogens are administered only after patients receive and understand their PPIs.

    Main Methods:

    • Developed a dual-approach system for PPI distribution: pharmacists dispense and verbally reinforce PPIs for outpatients, while a double-tab label system is used for inpatients.
    • For outpatients, pharmacists dispense PPIs with medication, record issuance, and verbally reinforce information.
    • For inpatients, a preprinted label on the PPI guides physicians, and physician confirmation of patient explanation is required before administration.

    Main Results:

    • The developed procedure demonstrated satisfactory compliance rates.
    • Physician compliance with the PPI procedure was achieved, with estrogens withheld until compliance was confirmed.
    • A notable decrease in the number of physicians prescribing estrogens and a reduction in prescribed estrogen products were observed concurrently.

    Conclusions:

    • The implemented PPI distribution procedure for estrogens appears effective in ensuring information delivery and physician compliance.
    • The satisfactory compliance may be influenced by a decrease in estrogen prescribing overall.
    • Further investigation may be needed to ascertain the long-term impact and effectiveness independent of prescribing trends.

    Related Experiment Videos